JENNIFER MUELLER: Open Payments
NPI 1922738145 · CAPE GIRARDEAU, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$558 in 23 payments from 14 companies in 2025. Trend: 2023 $150 · 2024 $245 · 2025 $558
Food & beverage: $558
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 2 | $139 |
| Novo Nordisk Inc | 3 | $65 |
| Philips North America LLC | 2 | $61 |
| Lilly USA, LLC | 3 | $53 |
| Novartis Pharmaceuticals Corporation | 2 | $42 |
| GlaxoSmithKline, LLC. | 2 | $34 |
| Amgen Inc. | 2 | $32 |
| Sumitomo Pharma America, Inc. | 1 | $25 |
| Viatris Specialty LLC | 1 | $22 |
| Verona Pharma, Inc. | 1 | $20 |
Products named: AIRSUPRA, Encore, MOUNJARO, Ozempic, LEQVIO, GEMTESA, Rybelsus, YUPELRI.
Industry payments across MO — which companies pay providers there.
